Ost P - Search Results

1

Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity.

Franco NR, Massi MC, Ieva F, Manzoni A, Paganoni AM, Zunino P, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Johnson K, Lambrecht M, Haustermans K, De Meerleer G, de Ruysscher D, Vanneste B, Van Limbergen E, Choudhury A, Elliott RM, Sperk E, Veldwijk MR, Herskind C, Avuzzi B, Noris Chiorda B, Valdagni R, Azria D, Farcy-Jacquet MP, Brengues M, Rosenstein BS, Stock RG, Vega A, Aguado-Barrera ME, Sosa-Fajardo P, Dunning AM, Fachal L, Kerns SL, Payne D, Chang-Claude J, Seibold P, West CML, Rancati T; REQUITE Consortium Collaborators. Franco NR, et al. Among authors: ost p. Radiother Oncol. 2021 Jun;159:241-248. doi: 10.1016/j.radonc.2021.03.024. Epub 2021 Apr 8. Radiother Oncol. 2021. PMID: 33838170 Free PMC article.

2

Short term toxicity profile for 32 sinonasal cancer patients treated with IMRT. Can we avoid dry eye syndrome?

Claus F, Boterberg T, Ost P, De Neve W. Claus F, et al. Among authors: ost p. Radiother Oncol. 2002 Aug;64(2):205-8. doi: 10.1016/s0167-8140(02)00172-x. Radiother Oncol. 2002. PMID: 12242131

3

Salvage intensity-modulated radiotherapy for rising PSA after radical prostatectomy.

De Meerleer G, Fonteyne V, Meersschout S, Van den Broecke C, Villeirs G, Lumen N, Ost P, Vandecasteele K, De Neve W. De Meerleer G, et al. Among authors: ost p. Radiother Oncol. 2008 Nov;89(2):205-13. doi: 10.1016/j.radonc.2008.07.027. Epub 2008 Sep 2. Radiother Oncol. 2008. PMID: 18771809

4

Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).

Ost P, Fonteyne V, De Neve W, De Gersem W, De Wagter C, Vandecasteele K, Duprez F, De Meerleer G. Ost P, et al. Int J Radiat Oncol Biol Phys. 2009 Mar 15;73(4):1286; author reply 1287. doi: 10.1016/j.ijrobp.2008.12.008. Int J Radiat Oncol Biol Phys. 2009. PMID: 19251105 No abstract available.

5

Adjuvant high-dose intensity-modulated radiotherapy after radical prostatectomy for prostate cancer: clinical results in 104 patients.

Ost P, Fonteyne V, Villeirs G, Lumen N, Oosterlinck W, De Meerleer G. Ost P, et al. Eur Urol. 2009 Oct;56(4):669-75. doi: 10.1016/j.eururo.2009.05.041. Epub 2009 May 29. Eur Urol. 2009. PMID: 19501453

6

Analysis of prostate bed motion using daily cone-beam computed tomography during postprostatectomy radiotherapy.

Ost P, De Meerleer G, De Gersem W, Impens A, De Neve W. Ost P, et al. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):188-94. doi: 10.1016/j.ijrobp.2009.10.029. Epub 2010 Apr 6. Int J Radiat Oncol Biol Phys. 2011. PMID: 20378272

7

Whole abdominopelvic radiotherapy using intensity-modulated arc therapy in the palliative treatment of chemotherapy-resistant ovarian cancer with bulky peritoneal disease: a single-institution experience.

De Meerleer G, Vandecasteele K, Ost P, Delrue L, Denys H, Makar A, Speleers B, Van Belle S, Van den Broecke R, Fonteyne V, De Neve W. De Meerleer G, et al. Among authors: ost p. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):775-81. doi: 10.1016/j.ijrobp.2009.11.039. Epub 2010 Apr 24. Int J Radiat Oncol Biol Phys. 2011. PMID: 20421155

8

Re: Michael L. Eisenberg, Benjamin J. Davies, Matthew R. Cooperberg, et al. Prognostic implications of an undetectable ultrasensitive prostate-specific antigen level after radical prostatectomy. Eur Urol 2010;57:622-30.

Ost P, Bossi A, De Meerleer G. Ost P, et al. Eur Urol. 2010 Sep;58(3):e33; author reply e34-5. doi: 10.1016/j.eururo.2010.05.006. Epub 2010 May 20. Eur Urol. 2010. PMID: 20537787 No abstract available.

9

Volumetric arc therapy and intensity-modulated radiotherapy for primary prostate radiotherapy with simultaneous integrated boost to intraprostatic lesion with 6 and 18 MV: a planning comparison study.

Ost P, Speleers B, De Meerleer G, De Neve W, Fonteyne V, Villeirs G, De Gersem W. Ost P, et al. Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):920-6. doi: 10.1016/j.ijrobp.2010.04.025. Epub 2010 Aug 2. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675077

10

A matched control analysis of adjuvant and salvage high-dose postoperative intensity-modulated radiotherapy for prostate cancer.

Ost P, De Troyer B, Fonteyne V, Oosterlinck W, De Meerleer G. Ost P, et al. Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1316-22. doi: 10.1016/j.ijrobp.2010.04.039. Epub 2010 Aug 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20675081

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

310 results

Search Page

Filters